SCHEMBL13023074

SCHEMBL13023074

CC(C)(O)C#Cc1cccc(NC(=O)Oc2cc(N)cc(OC(=O)Nc3cccc(C#CC(C)(C)O)c3)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.43
▸ HAO1 Q9UJM8 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ FAAH O00519 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PDK1 Q15118 1/20 0.39
▸ PDK2 Q15119 1/20 0.39
▸ PDK3 Q15120 1/20 0.39
▸ PDK4 Q16654 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ KMT2A Q03164 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13300036 0.94 EGFR (0.39) EGFRHAO1CYP1A2ALDH1A1FAAH
SCHEMBL13023058 0.80 KMT2A (0.45) EGFRCYP1A2ALDH1A1FAAHCYP3A4
SCHEMBL13023070 0.80 LMNA (0.47) EGFRLMNAL3MBTL1PDK1PDK2
SCHEMBL13022960 0.80 LMNA (0.47) EGFRLMNAL3MBTL1PDK1PDK2
SCHEMBL13066085 0.79 CYP1A2 (0.46) CYP1A2ALDH1A1FAAHCYP3A4MAPK1
SCHEMBL13022991 0.78 HAO1 (0.50) EGFRHAO1ALDH1A1CYP3A4LMNA
SCHEMBL845317 0.77 GRM5 (0.52) EGFRCYP1A2ALDH1A1L3MBTL1PDK1
SCHEMBL13023014 0.76 ALDH1A1 (0.45) EGFRHAO1CYP1A2ALDH1A1CYP3A4
SCHEMBL13023077 0.75 ALDH1A1 (0.45) EGFRALDH1A1LMNAL3MBTL1PDK1
SCHEMBL11008836 0.74 TP53 (0.52) EGFRHAO1LMNAL3MBTL1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 EGFR 3333/4885HAO1 2104/4885CYP1A2 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback